Fungal Otitis Externa Market Size, Share, Growth Analysis Report 2030

Author : Amol Shinde | Published On : 17 Apr 2024

Fungal Otitis Externa Market Overview 2030:

Fungal Otitis Externa Market size was estimated to be worth USD 170 million in 2021 and is expected to grow at a compound annual growth rate of 3.0% to reach approximately USD 220 million in 2030.

The illness known as fungal otitis externa results in inflammation (redness and swelling) of the external ear canal. Due to the increased susceptibility of the ear canal to inflammation caused by frequent exposure to water, fungal otitis externa is commonly known as swimmer's ear. Aspergillus is the most prevalent pathogen (80–90% of cases), with Candida coming in second. Prolonged treatment for bacterial otitis externa might change the ear canal's flora, leading to fungus infection.

When fungus produce fungal otitis externa, it is also referred to as "swimmer's ear" and affects the outer ear canal. Although bacterial infections are more frequent, 10% of instances of otitis externa are caused by fungus. The two most frequent types of fungi that cause this infection are Aspergillus and Candida.

Request for A Sample of This Research Report @

Fungal Otitis Externa Market Symptoms:

sensation: One of the first indications of a fungal infection is frequently a persistent itch in the ear canal.

Outflow: Depending on the type of fungus, there may be a white, yellow, or black discharge.

Ear pain: Pain may be minor to severe, and it may get worse when the ear is touched or moved.

Hearing loss: Swelling and fluid that obstruct the ear canal can cause temporary hearing loss.

Fullness or pressure: A common complaint among patients is that their ears feel full.

Market Growth:

The global fungal otitis externa market is poised for growth due to a robust product pipeline, particularly in the healthcare and pharmaceutical sectors. Major players are heavily investing in research and development to introduce new treatments for fungal otitis externa. For instance, Novus Therapeutics Inc., a U.S.-based pharmaceutical company, reported promising results from its phase 2a clinical trial of OP0201 for acute otitis externa in June 2020. These developments are expected to drive market growth over the forecast period.

However, the COVID-19 pandemic has had a detrimental impact on the growth of the global fungal otitis externa market. Nationwide lockdowns implemented by several countries to curb the spread of the virus led to temporary suspensions of manufacturing and construction activities. Moreover, the global supply chain faced significant disruptions due to restrictions on international trade and travel. Despite these challenges, the gradual easing of lockdown measures and declining COVID-19 cases present favourable opportunities for potential market growth.

Preventive measures

A single strategy to avoid fungal otitis externa is to:

Keeping ears dry: Pat dry your ears after taking a bath or swimming, and stay out of the water for a long time.

Keeping your ears safe: Don't stick cotton swabs or other things inside your ears.

Maintaining proper hygiene: cleansing the outer ear on a regular basis without putting anything in the canal.

Taking care of underlying conditions Manage any illnesses that could make a person more susceptible to infection, such as immune system problems or diabetes.

Market Segments:

By Type

  • Ear Drops
    • Clotrimazole
    • Fluconazole
    • Acetic Acid (2%)
  • Oral Medications
    • Itraconazole
    • NSAIDS
  • Topical Medications
  • Late Stage Pipeline Drugs

By Fungus Type

  • Aspergillus
  • Candida

By Route of Administration

  • Optic
  • Oral
  • Topical

By Distribution Channel

  • Hospital pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Get Customized Report @

Reason to Buy this Report:

  • Analysis of how technology advancements affect the market and how new trends will affect the sector in the years to come.
  • Examination of the impact of policy and regulatory modifications on the market and how they affect market players.
  • A synopsis of the market competitive environment for fungal otitis externa, encompassing market share, player profiles, and growth strategies.
  • Determination of the primary obstacles confronting the industry, including disturbances in the supply chain, ecological worries, and evolving consumer inclinations, and evaluation of the ways in which these obstacles may impact market expansion.
  • Evaluation of new product and application possibilities, as well as study of market participants' investment opportunities.

Market Regional Analysis:

North America is anticipated to have the biggest market share among all regions in the global market for fungal otitis externa during the projected timeframe. Due to the increasing incidence of fungal otitis externa in the United States, North America is anticipated to be the most lucrative area in the global fungal otitis externa market. According to the Centres for Disease Control and Prevention's May 2011 report, for example, one in 123 Americans experienced acute otitis externa in 2007; this condition was responsible for one in 324 ER visits and one in 481 ambulatory-care visits for the treatment of fungal otitis externa.

Market Key Players:

  1. Novartis
  2. Bayer AG
  3. Sanofi
  4. GlaxoSmithKline plc.
  5. AbbVie
  6. Par Pharmaceutical, Inc.
  7. Hi-Tech Pharma
  8. Actavis Mid-Atlantic
  9. Hill Derma cuticles Inc.
  10. Nullify Pharmaceuticals
  11. Glen mark Pharmaceuticals Limited
  12. Pfizer Inc.
  13. Janssen Pharmaceutical
  14. McNeil Consumer Healthcare
  15. Mylan N.V.
  16. Sal vat Laboratories
  17. Other players

Click Here for Purchase Report @

About We Market Research: 

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets. 

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients. 

Contact Us: 

Mr. Robbin Joseph 
Corporate Sales, USA 
We Market Research 
USA: +1-724-618-3925